Baseline ctDNA based hyperselection identified optimal candidates for panitumumab + mFOLFOX in mCRC. Primary tumor location only serves as surrogate predictor of the anti-EGFR benefit. 🧬 See our Bulletin for more:

Neoadjuvant FOLFIRINOX shows no benefit compared to upfront surgery in patients with resectable pancreatic adenocarcinoma; HR 1.52 (95% CI 1.00–2.33) - NORPACT-1🔪 See our Bulletin for more:

The addition of paclitaxel to 2L gemcitabine does not improve OS in metastatic pancreatic cancer; HR 0.87 (95% CI, 0.63-1.20) - GEMPAX. See ESDO Bullets for more 👇

🗓️Four weeks to go! ESDO EAES EDS AEGIS - an EFISDS initiative What constitutes high-quality guidelines? 👉 bit.ly/49EcXqg UEGJ my_UEG

a new ESDO LearningBytes tutorial is online: Cancer Related Fatigue (CrF) by Zineb Benbrahim, MD, MPH youtu.be/Qt5lfyBPeoo #cancer #fatigue #crf

We are excited to launch our position paper, developed with leading orgs Cancer Patients Europe, Digestive Cancers Europe, EPC-Europ Pancr Club, my_UEG, to combat #pancreaticcancer in Europe before the 2024 #EUElections! 🇪🇺 Download now to explore solutions and spread the word! shorturl.at/fgyE8

Don't miss our Bulletin spotlighting GI Oncology papers from April 2024! 🚨 my_UEG esdo.eu/publications-r…

📢 #Healthcare professionals and #community members - we need your #input! 📢 🗣️ Your #opinion matters! We are conducting a #survey to gather your valuable #insights and #feedback 🎗️ ✍️Take part: bit.ly/ONCODIR_survey #HealthcareSurvey #CRC #ColorectalCancer #Cancer #Health

Stay up-to-date with GI cancer updates from ASCO 2024! See our Bulletin covering mCRC (02 June) 🎗️ #GICancer #CancerResearch #ASCO24

ESDO Bulletin: Stay up-to-date with news in GI cancer from #ASCO24! ESOPEC: FLOT trumps CROSS in esophageal cancer!

Catch the latest updates on gastroesophageal cancer from #ASCO24 in ESDO Bullets! my_UEG

Get the latest news on pancreatic cancer from #ASCO24 in ESDO Bullets! my_UEG

Discover the latest insights on liver cancers from #ASCO24 in ESDO Bullets! my_UEG

#SaveTheDate Join us for the #ENTERO2024 Conference to learn about the latest research, treatments, and unique perspectives of patients, survivors, and caregivers on early-age onset #DigestiveCancers. 🗓️ 14-15 November 2024 📍Porto,🇵🇹 by invitation only or virtual 🖥️attendance

see you ESMO - Eur. Oncology GI Cancers Congress in Munich

🔬 Stay updated on GI oncology! Check out the ESDO Bullets: May 2024 pubs! esdo.eu/publications-r… my_UEG

Stay updated on GI oncology! 🔖 Check out the ESDO Bullets: June 2024 pubs! esdo.eu/publications-r…… my_UEG

📢 Stay up-to-date with the latest in GI oncology! Check out the ESDO Bullets Bulletin for July 2024! esdo.eu/publications-r… my_UEG

Listen to the latest ESDO podcast "Neoadjuvant immunotherapy in CRC: the future is now!" Ana-Maria Bucalau from ESDO Young Group interviewed Professor Francesco Sclafani Francesco Sclafani about data from the latest studies. Enjoy! esdo.eu/fileadmin/user…